1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt
C40H36CoN16O4 — CID 135983854
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt
1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt (PubChem CID 135983854) has the molecular formula C40H36CoN16O4 and a molecular weight of 863.77 g/mol. Its IUPAC name is 1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt.
Molecular Properties
| Compound Name | 1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt |
|---|---|
| PubChem CID | 135983854 |
| Molecular Formula | C40H36CoN16O4 |
| Molecular Weight | 863.77 g/mol |
| Exact Mass | 863.24 |
| IUPAC Name | 1-butyl-5-[(4-cyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-6-hydroxy-4-methyl-2-oxopyridine-3-carbonitrile;1-butyl-6-hydroxy-3-isocyano-5-[(4-isocyano-1-pyridin-2-ylpyrazol-5-yl)diazenyl]-4-methylpyridin-2-one;cobalt |
| SMILES | CCCCn1c(O)c(/N=N/c2c(C#N)cnn2-c2ccccn2)c(C)c(C#N)c1=O.[C-]#[N+]c1cnn(-c2ccccn2)c1/N=N/c1c(C)c([N+]#[C-])c(=O)n(CCCC)c1O.[Co] |
| InChI | InChI=1S/2C20H18N8O2.Co/c1-5-6-11-27-19(29)16(22-4)13(2)17(20(27)30)25-26-18-14(21-3)12-24-28(18)15-9-7-8-10-23-15;1-3-4-9-27-19(29)15(11-22)13(2)17(20(27)30)25-26-18-14(10-21)12-24-28(18)16-7-5-6-8-23-16;/h7-10,12,30H,5-6,11H2,1-2H3;5-8,12,30H,3-4,9H2,1-2H3;/b2*26-25+; |
| InChIKey | JWPSHTJKFOKUDY-PUUPLGBVSA-N |
| XLogP | 8.16 |
| TPSA | 251.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 863.77 |
| LogP ≤ 5 | 8.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135983854 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.